HON
Honeywell International Inc.
HON has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has a slight edge over HON overall, supported by stronger fundamentals and stronger modeled upside.
HON Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| Stable | |
| Healthy |
HON's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is weak.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HON PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $223 | — |
| Cheap | 20x | $438 | +96% |
| Fair | 23x | $515 | +130% |
| Forward | 24x | $223 | — |
| Expensive | 28x | $628 | +181% |
Historical ranges are pointers, not guarantees.
HON's PE is in its cheap range at 10x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 24x, in its fair range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
HON Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Strong decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect HON's profitability to improve, but its revenue to decline.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over HON on the outlook, with more favorable earnings and revenue expectations.
HON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.49 | -57% |
| Q3 2026 | $22.13 | +17% |
| Q2 2026 | $25.77 | +47% |
| Q1 2026 | $12.84 | -26% |
| Q4 2025 | $14.70 | -16% |
| Q3 2025 | $18.98 | +9.6% |
| Q2 2025 | $17.58 | +0.2% |
| Q1 2025 | $17.40 | +0.8% |
| Q4 2024 | $17.42 | +2.8% |
HON has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
HON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5B | -52% |
| Q2 2026 | $9.7B | -6.1% |
| Q1 2026 | $9.1B | -6.9% |
| Q4 2025 | $9.8B | -3.3% |
| Q3 2025 | $10.4B | +7% |
| Q2 2025 | $10.4B | +8.1% |
| Q1 2025 | $9.8B | +7.9% |
| Q4 2024 | $10.1B | +6.9% |
HON's revenue has slid since its 2025 peak: $5B last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -1.9 points |
| Q2 2026 | 23% | +0.2 points |
| Q1 2026 | 23% | +0.3 points |
| Q4 2025 | 11% | -9.7 points |
| Q3 2025 | 23% | -0.5 points |
| Q2 2025 | 23% | -0.1 points |
| Q1 2025 | 23% | +0.8 points |
| Q4 2024 | 21% | +5 points |
HON has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over HON on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
HON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $286M | -90% |
| Q2 2026 | $961M | -5.4% |
| Q1 2026 | -$873M | -352% |
| Q4 2025 | $1.1B | -39% |
| Q3 2025 | $2.9B | +70% |
| Q2 2025 | $1B | -8.6% |
| Q1 2025 | $346M | +61% |
| Q4 2024 | $1.9B | -27% |
HON has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
HON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +600K shares |
| 1 year | -0.1% | -200K shares |
| 3 years | -4.3% | -14.3M shares |
| 5 years | -8.7% | -30.3M shares |
| Available history | -13% | -46M shares |
HON has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $1B |
| Q4 2025 | $100M |
| Q3 2025 | $100M |
| Q2 2025 | $1.7B |
| Q1 2025 | $1.9B |
| Q4 2024 | $455M |
HON spent $1.1B buying back its own shares over the past year, down 74% from the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
HON's net debt is about 1.4 years of its operating earnings (EBITDA), down from 2.3 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.9 | Neutral |
| Stochastic | 45.0 | Neutral |
HON's weekly RSI is 52 (neutral) and its Stochastic is 45 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
HON PE vs Industrials Sector
| Metric | HON | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 24x | 58% below |
| PE % | 4 | 58 | 54 pts below |
HON is trading at 10x earnings, a 58% discount to the Industrials sector's median of 24x, though its recent earnings include one-off gains.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
HON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $216.1 | 3.4% above |
| 20 week MA | $221.4 | 0.9% above |
| 50 week MA | $223.8 | 0.1% below |
| 100 week MA | $215.2 | 3.9% above |
| 200 week MA | $203.7 | 9.7% above |
HON has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
HON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $169.2 | $200.8 | +19% |
| 2021 | $200.8 | $196.7 | -2.1% |
| 2022 | $196.7 | $205.0 | +4.2% |
| 2023 | $205.0 | $201.0 | -1.9% |
| 2024 | $201.0 | $220.0 | +9.4% |
| 2025 | $220.0 | $200.7 | -8.8% |
| 2026 YTD | $200.7 | $223.5 | +11% |
HON has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.